159 related articles for article (PubMed ID: 29971034)
21. Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma.
Hartman DJ; Binion D; Regueiro M; Schraut W; Bahary N; Sun W; Nikiforova M; Pai RK
Am J Surg Pathol; 2014 Aug; 38(8):1147-56. PubMed ID: 25029120
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.
Oka H; Scheithauer BW
Neurol Med Chir (Tokyo); 1999 Jul; 39(7):510-7; discussion 517-8. PubMed ID: 10437379
[TBL] [Abstract][Full Text] [Related]
23. IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain.
Lopez GY; Reitman ZJ; Solomon D; Waldman T; Bigner DD; McLendon RE; Rosenberg SA; Samuels Y; Yan H
Biochem Biophys Res Commun; 2010 Jul; 398(3):585-7. PubMed ID: 20603105
[TBL] [Abstract][Full Text] [Related]
24. Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations.
Toth LN; de Abreu FB; Tafe LJ
Hum Pathol; 2018 Aug; 78():138-143. PubMed ID: 29723602
[TBL] [Abstract][Full Text] [Related]
25. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
[TBL] [Abstract][Full Text] [Related]
26. The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.
Wang HY; Tang K; Liang TY; Zhang WZ; Li JY; Wang W; Hu HM; Li MY; Wang HQ; He XZ; Zhu ZY; Liu YW; Zhang SZ
J Exp Clin Cancer Res; 2016 May; 35():86. PubMed ID: 27245697
[TBL] [Abstract][Full Text] [Related]
27. Brain and Spinal Cord Tumors of Embryonic Origin.
Lampros M; Alexiou GA
Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
[TBL] [Abstract][Full Text] [Related]
28. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
Bleeker FE; Lamba S; Leenstra S; Troost D; Hulsebos T; Vandertop WP; Frattini M; Molinari F; Knowles M; Cerrato A; Rodolfo M; Scarpa A; Felicioni L; Buttitta F; Malatesta S; Marchetti A; Bardelli A
Hum Mutat; 2009 Jan; 30(1):7-11. PubMed ID: 19117336
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
30. Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
Brooks AM; Vornoli A; Kovi RC; Ton TVT; Xu M; Mashal A; Tibaldi E; Gnudi F; Li JL; Sills RC; Bucher JR; Mandrioli D; Belpoggi F; Pandiri AR
PLoS One; 2024; 19(1):e0296699. PubMed ID: 38232086
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
32. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
[TBL] [Abstract][Full Text] [Related]
33. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
[TBL] [Abstract][Full Text] [Related]
34. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
[TBL] [Abstract][Full Text] [Related]
35. Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers.
Raynaud S; Carbuccia N; Colin C; Adélaïde J; Mozziconacci MJ; Metellus P; Chinot O; Birnbaum D; Chaffanet M; Figarella-Branger D
Oncol Lett; 2010 Sep; 1(5):883-884. PubMed ID: 22966399
[TBL] [Abstract][Full Text] [Related]
36. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
[TBL] [Abstract][Full Text] [Related]
37. Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Yeo KK; Alexandrescu S; Cotter JA; Vogelzang J; Bhave V; Li MM; Ji J; Benhamida JK; Rosenblum MK; Bale TA; Bouvier N; Kaneva K; Rosenberg T; Lim-Fat MJ; Ghosh H; Martinez M; Aguilera D; Smith A; Goldman S; Diamond EL; Gavrilovic I; MacDonald TJ; Wood MD; Nazemi KJ; Truong A; Cluster A; Ligon KL; Cole K; Bi WL; Margol AS; Karajannis MA; Wright KD
Neuro Oncol; 2023 Jan; 25(1):199-210. PubMed ID: 35604410
[TBL] [Abstract][Full Text] [Related]
38. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
Koral K; Gargan L; Bowers DC; Gimi B; Timmons CF; Weprin B; Rollins NK
AJR Am J Roentgenol; 2008 Mar; 190(3):809-14. PubMed ID: 18287456
[TBL] [Abstract][Full Text] [Related]
39. Co-occurrence of schwannomatosis and rhabdoid tumor predisposition syndrome 1.
Kehrer-Sawatzki H; Kordes U; Seiffert S; Summerer A; Hagel C; Schüller U; Farschtschi S; Schneppenheim R; Bendszus M; Godel T; Mautner VF
Mol Genet Genomic Med; 2018 May; 6(4):627-37. PubMed ID: 29779243
[TBL] [Abstract][Full Text] [Related]
40. Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups.
Robbins CJ; Bou-Dargham MJ; Sanchez K; Rosen MC; Sang QA
J Cancer; 2018; 9(24):4596-4610. PubMed ID: 30588243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
